Drawing for RELATION

USPTO serial 79381308

RELATION

Reviewed by CopyMark Law Group

Reg. 7674099Status 700Registered
Filing date
Status date
Registration date
Feb 4, 2025
Examiner
CLARK, ANDREW T
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RELATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David E. Weslow

David E. Weslow Wiley Rein LLP2050 M Street NW70 KingswayWashington, DC 20036

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and medical preparations for the treatment of bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic diseaseACTIVE—
009Downloadable computer software for development of treatments for bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic disease; Downloadable science software for analyzing scientific research data and managing research studies; Downloadable bioinformatics computer software for analyzing bioinformatics data and managing research studies; Downloadable computer software using artificial intelligence (AI) for development of treatments for bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic disease; Electronic downloadable publications in the nature of articles, books and reports in the field of bone disease, immunology, neuroscience, dermatological disorders and metabolic diseaseACTIVE—
042Scientific research relating to biology; testing of pharmaceuticals; pharmaceutical products development; research of pharmaceuticals; drug discovery and development services; software-as-a-service (SAAS) services featuring software for development of treatments for bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic disease; technical data analysis services for scientific research purposes; medical laboratory services; scientific, medical and pharmaceutical research and development services; information, advisory and consultancy services in relation to the aforesaid.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 4, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 4, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 17, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 17, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2024RFNTREFUSAL PROCESSED BY IB—
May 23, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 23, 2024RFRRREFUSAL PROCESSED BY MPU—
May 14, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 13, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2024DOCKASSIGNED TO EXAMINER—
Oct 31, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 25, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance